Interest Paid, Excluding Capitalized Interest, Operating Activities in USD of Vitro Biopharma, Inc. from Q4 2021 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from Q4 2021 to Q4 2024.
- Vitro Biopharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Jan 2025 was $4.22K, a 13.8% decline year-over-year.
- Vitro Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $19.5K, a 9.61% decline from 2023.
- Vitro Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $21.6K, a 63.8% decline from 2022.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)